CD20-Positive Large B-Cell Lymphoma
1 clinical trials · Condition
◉ Watch CD20-Positive Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma (NCT00169169) | Lymphoma Study Association | 1999-10-01 |
Track CD20-Positive Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.